Výsledky vyhledávání - Rojo, Ricardo

  • Zobrazuji výsledky 1 - 16 z 16
Upřesnit hledání
  1. 1
    Safety signal detection and evaluation in clinical development programs: A case study of tofacitinib

    Safety signal detection and evaluation in clinical development programs: A case study of tofacitinib Autor Dasic, Gorana, Jones, Thomas, Frajzyngier, Vera, Rojo, Ricardo, Madsen, Ann, Valdez, Hernan

    Vydáno 2017
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial

    Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women... Autor Kimani, Joshua, Phiri, Kamija, Kamiza, Steve, Duparc, Stephan, Ayoub, Ayman, Rojo, Ricardo, Robbins, Jeffery, Orrico, Russell, Vandenbroucke, Pol

    Vydáno 2016
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with Plasmodium Falciparum Parasitemia: An Open-Label, Non-Comparative Study in Sub-Saharan Africa

    Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with Plasmodium Falciparum Parasitemi... Autor Phiri, Kamija, Kimani, Joshua, Mtove, George A., Zhao, Qinying, Rojo, Ricardo, Robbins, Jeffery, Duparc, Stephan, Ayoub, Ayman, Vandenbroucke, Pol

    Vydáno 2016
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settings

    Multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settings Autor Mtove, George, Kimani, Joshua, Kisinza, William, Makenga, Geofrey, Mangesho, Peter, Duparc, Stephan, Nakalembe, Miriam, Phiri, Kamija S., Orrico, Russell, Rojo, Ricardo, Vandenbroucke, Pol

    Vydáno 2018
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study

    Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study Autor Buttgereit, Frank, Strand, Vibeke, Lee, Eun Bong, Simon-Campos, Abraham, McCabe, Dorothy, Genet, Astrid, Tammara, Brinda, Rojo, Ricardo, Hey-Hadavi, Judith

    Vydáno 2019
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial

    Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial Autor Silverberg, Jonathan I., Simpson, Eric L., Thyssen, Jacob P., Gooderham, Melinda, Chan, Gary, Feeney, Claire, Biswas, Pinaki, Valdez, Hernan, DiBonaventura, Marco, Nduaka, Chudy, Rojo, Ricardo

    Vydáno 2020
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes

    Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Pa... Autor Silverberg, Jonathan I., Thyssen, Jacob P., Simpson, Eric L., Yosipovitch, Gil, Ständer, Sonja, Valdez, Hernan, Rojo, Ricardo, Biswas, Pinaki, Myers, Daniela E., Feeney, Claire, DiBonaventura, Marco

    Vydáno 2021
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes

    Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled... Autor Silverberg, Jonathan I., Thyssen, Jacob P., Simpson, Eric L., Yosipovitch, Gil, Ständer, Sonja, Valdez, Hernan, Rojo, Ricardo, Biswas, Pinaki, Myers, Daniela E., Feeney, Claire, DiBonaventura, Marco

    Vydáno 2021
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Tofacitinib, an oral Janus kinase inhibitor, in patients from Brazil with rheumatoid arthritis: Pooled efficacy and safety analyses

    Tofacitinib, an oral Janus kinase inhibitor, in patients from Brazil with rheumatoid arthritis: Pooled efficacy and safety analyses Autor Lomonte, Andrea B.V., Radominski, Sebastião C., Marcolino, Flora M.D., Brenol, Claiton V., Zerbini, Cristiano A.F., García, Erika G., Akylbekova, Ermeg L., Rojo, Ricardo, de Leon, Dario Ponce

    Vydáno 2018
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE

    Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE Autor Gooderham, Melinda J., Chu, Chia-Yu, Rojo, Ricardo, Valdez, Hernan, Biswas, Pinaki, Cameron, Michael C., Feeney, Claire, Encinas, Gerardo A., Peeples-Lamirande, Kathleen, Cappelleri, Joseph C., Myers, Daniela E., DiBonaventura, Marco

    Vydáno 2021
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis: The JADE TEEN Randomized Clinical Trial

    Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis: The JADE TEEN Randomized Clinical Trial Autor Eichenfield, Lawrence F., Flohr, Carsten, Sidbury, Robert, Siegfried, Elaine, Szalai, Zsuzsanna, Galus, Ryszard, Yao, Zhirong, Takahashi, Hidetoshi, Barbarot, Sébastien, Feeney, Claire, Zhang, Fan, DiBonaventura, Marco, Rojo, Ricardo, Valdez, Hernan, Chan, Gary

    Vydáno 2021
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program

    Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program Autor Simpson, Eric L., Silverberg, Jonathan I., Nosbaum, Audrey, Winthrop, Kevin L., Guttman-Yassky, Emma, Hoffmeister, Karin M., Egeberg, Alexander, Valdez, Hernan, Zhang, Min, Farooqui, Saleem A., Romero, William, Thorpe, Andrew J., Rojo, Ricardo, Johnson, Susan

    Vydáno 2021
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Correction to: Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program

    Correction to: Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program Autor Simpson, Eric L., Silverberg, Jonathan I., Nosbaum, Audrey, Winthrop, Kevin L., Guttman-Yassky, Emma, Hoffmeister, Karin M., Egeberg, Alexander, Valdez, Hernan, Zhang, Min, Farooqui, Saleem A., Romero, William, Thorpe, Andrew J., Rojo, Ricardo, Johnson, Susan

    Vydáno 2021
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  14. 14
    An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data

    An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data Autor Burmester, Gerd R., Curtis, Jeffrey R., Yun, Huifeng, FitzGerald, Oliver, Winthrop, Kevin L., Azevedo, Valderilio F., Rigby, William F. C., Kanik, Keith S., Wang, Cunshan, Biswas, Pinaki, Jones, Thomas, Palmetto, Niki, Hendrikx, Thijs, Menon, Sujatha, Rojo, Ricardo

    Vydáno 2020
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  15. 15
    COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study

    COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study Autor Jurado, Aurora, Martín, María C., Abad-Molina, Cristina, Orduña, Antonio, Martínez, Alba, Ocaña, Esther, Yarce, Oscar, Navas, Ana M., Trujillo, Antonio, Fernández, Luis, Vergara, Esther, Rodríguez, Beatriz, Quirant, Bibiana, Martínez-Cáceres, Eva, Hernández, Manuel, Perurena-Prieto, Janire, Gil, Juana, Cantenys, Sergi, González-Martínez, Gema, Martínez-Saavedra, María T., Rojo, Ricardo, Marco, Francisco M., Mora, Sergio, Ontañón, Jesús, López-Hoyos, Marcos, Ocejo-Vinyals, Gonzalo, Melero, Josefa, Aguilar, Marta, Almeida, Delia, Medina, Silvia, Vegas, María C., Jiménez, Yesenia, Prada, Álvaro, Monzón, David, Boix, Francisco, Cunill, Vanesa, Molina, Juan

    Vydáno 2020
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:
  16. 16
    The age again in the eye of the COVID-19 storm: evidence-based decision making

    The age again in the eye of the COVID-19 storm: evidence-based decision making Autor Martín, María C., Jurado, Aurora, Abad-Molina, Cristina, Orduña, Antonio, Yarce, Oscar, Navas, Ana M., Cunill, Vanesa, Escobar, Danilo, Boix, Francisco, Burillo-Sanz, Sergio, Vegas-Sánchez, María C., Jiménez-de las Pozas, Yesenia, Melero, Josefa, Aguilar, Marta, Sobieschi, Oana Irina, López-Hoyos, Marcos, Ocejo-Vinyals, Gonzalo, San Segundo, David, Almeida, Delia, Medina, Silvia, Fernández, Luis, Vergara, Esther, Quirant, Bibiana, Martínez-Cáceres, Eva, Boiges, Marc, Alonso, Marta, Esparcia-Pinedo, Laura, López-Sanz, Celia, Muñoz-Vico, Javier, López-Palmero, Serafín, Trujillo, Antonio, Álvarez, Paula, Prada, Álvaro, Monzón, David, Ontañón, Jesús, Marco, Francisco M., Mora, Sergio, Rojo, Ricardo, González-Martínez, Gema, Martínez-Saavedra, María T., Gil-Herrera, Juana, Cantenys-Molina, Sergi, Hernández, Manuel, Perurena-Prieto, Janire, Rodríguez-Bayona, Beatriz, Martínez, Alba, Ocaña, Esther, Molina, Juan

    Vydáno 2021
    Získat plný text Získat plný text Získat plný text
    Text
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: